超越多能性:Yamanaka因素驱动大脑生长和再生
Sunwoo Choi1, Mingzi Zhang1, Ruslan Rust1
1Department of Physiology and Neuroscience, University of Southern California, Los Angeles, CA 90033, USA; Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
Trends in molecular medicine
|December 12, 2024
概括
在小鼠大脑中Yamanaka因子 (YFs) 的过渡表达促进皮质发育并减轻阿尔茨海默病的症状. 这项研究突显了YFs在神经学应用中的潜力,超出了多能性.
科学领域:
- 神经科学是一个神经科学.
- 发展生物学 发展生物学
- 干细胞生物学 干细胞生物学
背景情况:
- 雅曼卡因子 (Yamanaka factors,简称YFs) 是一种已知能诱导体细胞多能性的转录因子.
- 它们在神经退行性疾病中的潜在治疗应用在很大程度上仍未被探索.
研究的目的:
- 为了研究短暂的Yamanaka因子表达在发育中的小鼠大脑中的影响.
- 在阿尔茨海默氏病模型中评估YFs对皮质发育和认知功能的影响.
主要方法:
- 在小鼠大脑中利用了Yamanaka因子的短暂表达.
- 研究了对皮质发育和神经发生的影响.
- 在阿尔茨海默病的小鼠模型中评估认知功能.
主要成果:
- 过渡的YF表达导致小鼠皮层的显著扩张.
- 在阿尔茨海默氏病模型中,YF治疗可以预防认知能力下降.
- 证明了YF在神经发育和保护中的新角色.
结论:
- 过渡的Yamanaka因子表达为增强大脑发育提供了一个有希望的策略.
- YFs显示出在阿尔茨海默病和其他神经系统疾病中治疗干预的潜力.
相关概念视频
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Neurogenesis and Regeneration of Nervous Tissue
717
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
717
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Neuroplasticity
295
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
295
Role of Hematopoietic Growth Factors
1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.2K
General Transcription Factors
5.2K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.2K


